PDA Journal of Pharmaceutical Science and Technology: 70 (5)

September/October 2016; Volume 70,Issue 5

Conference Proceeding

You have access
Introduction: Proceedings of the 2015 Viral Clearance Symposium
Glen Bolton and Rich Levy

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 409; DOI: https://doi.org/10.5731/pdajpst.2016.006874
You have access
Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation
Junfen Ma and David Roush

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 410-416; DOI: https://doi.org/10.5731/pdajpst.2016.006890
You have access
Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration
David Roush and Junfen Ma

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 417-427; DOI: https://doi.org/10.5731/pdajpst.2016.006916
You have access
Session 2: Company-Specific Data on Cycled Resin Testing
Johannes Blümel and Kurt Brorson

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 428-442; DOI: https://doi.org/10.5731/pdajpst.2016.006924
You have access
Session 3.1: Protein A, Hydroxyapatite, and Mixed-Mode Chromatography
Dayue Chen

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 443-450; DOI: https://doi.org/10.5731/pdajpst.2016.006932
You have access
Session 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.
Christopher Gallo

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 451-461; DOI: https://doi.org/10.5731/pdajpst.2016.006940
You have access
Session 4.1: Case Studies of Application of Generic Claims and QbD for Viral Clearance
Rachel Specht and Meisam Bakhshayeshi

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 462-469; DOI: https://doi.org/10.5731/pdajpst.2016.006957
You have access
Session 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies
Meisam Bakhshayeshi and Rachel Specht

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 470-476; DOI: https://doi.org/10.5731/pdajpst.2016.006965
You have access
Session 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
Glen Bolton and Johannes Blümel

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 477-481; DOI: https://doi.org/10.5731/pdajpst.2016.006973

Pda Paper

You have access
PDA Points To Consider: Fundamental Concepts in Data Integrity
Bob Buhlmann, Madlene Dole and Zena Kaufmann

PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062

Main menu

User menu

Search

Table of Contents

Conference Proceeding

Pda Paper

In This Issue

Jump to

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.